O

orca bio

Overview

Total employees218
Departments20
Locations3

Orca Bio is a clinical-stage biotechnology company revolutionizing allogeneic cell therapies with a focus on high-precision, engineered cell populations to treat cancers, autoimmune diseases, and genetic blood disorders. Operating within the rapidly evolving cell and gene therapy sector, Orca Bio is strategically positioned as a leader in developing next-generation immunotherapies designed to selectively target and eliminate diseased cells while preserving a functional immune system. Their Orca-T platform aims to overcome the limitations of traditional bone marrow transplants by delivering purified, precisely defined cell populations, reducing toxicities, and ultimately improving patient outcomes, thereby establishing a competitive edge in a crowded market.

orca bio's headcount breakdown by department

DepartmentHeadCount
Administrative
2
Consulting
2
Service
1
Design
0
Education
0
Finance
6
Management
7
Hr
3
Legal
0
Marketing
3
Medical
6
Operations
29
Department
29
Product
2
Management
1
Estate
0
Research
41
Sales
1
Technical
15
Trades
0

Orca Bio's departmental structure reveals a company deeply committed to research, development, and clinical translation of its cell therapy products. The significant investment in 'Research' (41 employees) underscores their dedication to innovation and scientific discovery, essential for refining their Orca-T platform and expanding their pipeline. A substantial 'Operations' team (29 employees) indicates a focus on scaling up manufacturing and ensuring robust quality control processes, critical for cell therapy production. The 'Other Department' category (29 employees) likely encompasses specialized functions unique to their allogeneic cell processing, potentially including logistics, cryopreservation, and advanced data analysis. A 'Technical' department (15 employees) provides the necessary engineering and IT infrastructure to support complex manufacturing and research activities. The 'Medical' team (6 employees) plays a vital role in overseeing clinical trials, interacting with physicians, and managing regulatory submissions. The smaller 'Sales' and 'Marketing' teams reflect the company's current focus on clinical development and securing regulatory approvals, with commercialization efforts likely to expand as their lead product approaches market launch. This workforce composition clearly demonstrates a strong emphasis on R&D, manufacturing excellence, and clinical execution, aligning with Orca Bio's strategy of developing and bringing innovative cell therapies to market.

orca bio's employees by locations

Employee Count by Country

Total: 147 employees

146
United States
99.3%
1
Switzerland
0.7%

Orca Bio's geographic footprint is primarily concentrated in the United States (146 employees), reflecting a strategic decision to leverage the country's advanced biotechnology infrastructure, skilled workforce, and favorable regulatory environment. This domestic focus enables efficient coordination of research, manufacturing, and clinical trial activities, facilitating rapid progress in their clinical programs. The limited international presence, with a single employee in Switzerland, potentially signals a strategic foothold for future European expansion or collaboration with research institutions within Switzerland's renowned biotechnology sector. The additional employee with unknown location most likely reflects the company's growing international operations and the need to recruit skilled personnel worldwide. Given the complexity of cell therapy manufacturing and the stringent regulatory requirements, Orca Bio's concentrated US-based operations provide a solid foundation for product development and commercialization, while the potential for European expansion suggests a forward-looking approach to accessing global markets.

Want to stay ahead of orca bio's org changes?

Get alerts when hiring spikes or teams shift focus

Track changes vs. competitors

Spot warm GTM signals early

orca bio Headcount by Region & Department | Highperform AI